These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17523730)

  • 1. Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy : An Open-Label Pilot Study.
    Hotta N; Yasuda K; Sumita Y; Sano T; Kakuta H; Nagashima M; Hayashi Y; Yamamoto M; Wakao T; Okuyama M; Kobayashi M; Mori K
    Clin Drug Investig; 2004; 24(11):671-80. PubMed ID: 17523730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy.
    Hotta N; Sugimura K; Tsuchida I; Sano T; Koh N; Matsumae H; Sakamoto N
    Clin Ther; 1994; 16(6):1007-15. PubMed ID: 7697680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of subjective symptoms of coldness and numbness in the upper and lower limbs among patients with vibration syndrome].
    Sakakibara H; Miyao M; Kondo T; Furuta M; Yamada S; Harada N; Miyake S; Hosokawa M
    Sangyo Igaku; 1989 Jul; 31(4):196-202. PubMed ID: 2555611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of goshajinkigan, a herbal medicine, on subjective symptoms and vibratory threshold in patients with diabetic neuropathy.
    Tawata M; Kurihara A; Nitta K; Iwase E; Gan N; Onaya T
    Diabetes Res Clin Pract; 1994 Dec; 26(2):121-8. PubMed ID: 7705193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test-retest and time dependent variation and diagnostic values of vibratory sensation determined by biothesiometer and the Rydel-Seiffer tuning fork.
    Wittenberg B; Svendsen TK; Gaist LM; Itani M; Gylfadottir SS; Jensen TS; Gaist D; Sindrup SH; Krøigård T
    Brain Behav; 2021 Aug; 11(8):e2230. PubMed ID: 34087955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective.
    Sharma SR; Sharma N
    Ann Indian Acad Neurol; 2008 Oct; 11(4):231-5. PubMed ID: 19893679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifteen-day acupuncture treatment relieves diabetic peripheral neuropathy.
    Tong Y; Guo H; Han B
    J Acupunct Meridian Stud; 2010 Jun; 3(2):95-103. PubMed ID: 20633522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Vibro-medical insole on vibrotactile sensation in diabetic patients with mild-to-moderate peripheral neuropathy.
    Bagherzadeh Cham M; Mohseni-Bandpei MA; Bahramizadeh M; Kalbasi S; Biglarian A
    Neurol Sci; 2018 Jun; 39(6):1079-1084. PubMed ID: 29594830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal of a new method for the use of the Rydel-Seiffer tuning fork in the screening of diabetic polyneuropathy. A pilot study.
    de Simone R; Rabitti PG; De Feo EM; Manguso F; Piscopo G; Scionti L
    Diabetes Res Clin Pract; 2015 May; 108(2):e21-4. PubMed ID: 25773377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group.
    Martina IS; van Koningsveld R; Schmitz PI; van der Meché FG; van Doorn PA
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):743-7. PubMed ID: 9810949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication.
    Gin H; Rigalleau V; Baillet L; Rabemanantsoa C
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):457-61. PubMed ID: 12522325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibration perception threshold and the law of mobility in diabetic mellitus patients.
    Manivannan M; Periyasamy R; Narayanamurthy VB
    Prim Care Diabetes; 2009 Feb; 3(1):17-21. PubMed ID: 19071079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
    J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perception of vibration. Normal findings and methodologic aspects].
    Claus D; Carvalho VP; Neundörfer B; Blaise JF
    Nervenarzt; 1988 Mar; 59(3):138-42. PubMed ID: 3374714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat.
    Kuzumoto Y; Kusunoki S; Kato N; Kihara M; Low PA
    Diabetologia; 2006 Dec; 49(12):3085-93. PubMed ID: 17063327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T; Matsubara A; Taniguchi K; Ogura Y
    Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.
    Steele JW; Faulds D; Goa KL
    Drugs Aging; 1993; 3(6):532-55. PubMed ID: 8312678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
    Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
    Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.